Rahul Shah
Neurocritical Care · Shreveport, LANPI 1073860938
Payments from drug & device makers
Across 87 payments — averaging $133.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$3K
- Medical Device Business Services, Inc.$3K
- Stryker$2K
- Scientia Vascular$1K
- Johnson & Johnson$401
- Microvention, Inc.$307
- plus $1K from 13 others
What the payments were for
- Travel & lodging$5,87951%
- Food & beverage$5,72149%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 19 | $3,408 |
| Medical Device Business Services, Inc. | 19 | $3,068 |
| Stryker | 10 | $2,143 |
| Scientia Vascular | 2 | $1,028 |
| Johnson & Johnson | 7 | $401 |
| Microvention, Inc. | 3 | $307 |
| Jazz Pharmaceuticals Inc. | 10 | $211 |
| AstraZeneca(2 entities) | 3 | $163 |
| Chiesi USA, Inc. | 2 | $155 |
| Balt USA, LLC | 1 | $150 |
| UCB, Inc. | 1 | $144 |
| Qapel Medical Inc | 1 | $101 |
| Amgen | 1 | $99 |
| Route 92 Medical, Inc. | 1 | $74 |
| TG Therapeutics, Inc. | 2 | $60 |
| Terumo Medical Corporation | 2 | $33 |
| Neurelis, Inc. | 1 | $26 |
| EMD Serono, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRUFILL$2,685
- Penumbra System$2,104
- SURPASS EVOLVE$1,804
- CEREPAK UNIFORM$1,168
- Cerenovus Enterprise$1,036
- EMBOGUARD$1,036
- Embotrap$1,030
- Socrates 38$1,028
- Colossus$1,028
- Aristotle$617
- RED 72$616
- Plato 17$411
- TARGET$157
- Carrier Delivery Catheter$150
- Fintepla$144
- CEREBASE$142
- PROWLER$142
- WEB Aneurysm Embolization System$140
- Penumbra Coil 400$139
- CLEVIPREX$130
How this compares
Too few neurocritical care providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurocritical care in Shreveport
- Lucido Ponce MejiaNew Orleans$72K
- Alan VelanderMarrero$22K
- Namir KhandkerNew Orleans$485
- Louis CannizzaroNew Orleans$421
- Barak BarNew Orleans$239
- Anita MallyaNew Orleans$28
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.